TA-ERT is a fusion protein comprised of recombinant human NAGLU and a truncated human IGF-2 connected via an amino acid linker ... The incidence is about 100,000 and 200,000 live births. The disease ...

The company hopes to push the rare-disease treatment toward FDA approval next year. Four months after ditching its lead drug, ...